Skip to content

Efficacy Observation and Mechanism Research of Transcatheter Arterial Chemoembolization, Hepatic Arterial Infusion Chemotherapy Combined with Targeted and Immunotherapy, and Hepatic Arterial Infusion Chemotherapy Combined with Targeted and Immunotherapy in the Treatment of Advanced Hepatocellular Carcinoma

Efficacy Observation and Mechanism Research of Transcatheter Arterial Chemoembolization, Hepatic Arterial Infusion Chemotherapy Combined with Targeted and Immunotherapy, and Hepatic Arterial Infusion Chemotherapy Combined with Targeted and Immunotherapy in the Treatment of Advanced Hepatocellular Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117267
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-01-21
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary liver cancer

Interventions

Observation Group for Treatment of Primary Liver Cancer:None

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 2. Gender: No restrictions on gender (male or female) 3. Patients with advanced liver cancer who received TACE and HAIC interventional surgeries at Nanfang Hospital of Southern Medical University from January 2021 to December 2023, and they did not visit the hospital later 4. Complete clinical and imaging data are available

Exclusion criteria

Exclusion criteria: 1. Liver function: Child-Pugh grade C; 2. Complicated with coagulation dysfunction or autoimmune diseases; 3. Had used other treatment regimens before; 4. Advanced liver cancer patients who, in the judgment of the investigators, were not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Overall survival period;

Secondary

MeasureTime frame
Objective response rate;

Countries

China

Contacts

Public ContactShuiying Tang

Southern Medical University Southern Hospital

tangsy926@163.com+86 20 62787177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026